Panbela Therapeutics Inc reports results for the quarter ended in December - Earnings Summary

Panbela Therapeutics

24/03/2022 21:56

* Panbela Therapeutics Inc  PBLA.OQ  reported a quarterly
adjusted
loss of 26 cents​​ per share for the quarter ended in December.
The mean expectation of three analysts for the quarter was for a
loss of 18 cents per share.
    * Reported revenue was zero​;  analysts expected zero. 
    * Panbela Therapeutics Inc's reported EPS for the quarter
was a
loss of 26 cents​.
    * The mean earnings estimate of analysts had fallen by
about 10.2%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Panbela Therapeutics Inc shares had risen by 18.5% this
quarter.
    * The company reported a quarterly loss of $3.54 million.
    * Wall Street's median 12-month price target for Panbela
Therapeutics Inc is $6.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated March 24 at 09:56 p.m.  ​All
figures in US dollars unless otherwise stated